Dashboard
Financial statements
CVS

Company financials

CVS Health

Health Care Health Care Services Woonsocket, Rhode Island Last filing Feb 10, 2026 · FY2025
Revenue FY2025
$402.1B
3y CAGR +7.6% P63
Net income FY2025
$1.8B
Net margin +0.4% P10
Total assets FY2025
$253.5B
ROA +0.7% P10
Operating cash flow FY2025
$10.6B
FCF margin +1.9% P18
20 yrs · FY1989–FY2025 17 gaps (2006–1990) 9 filed · 0 derived · 0 blank

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

32 accounts · 10 years
Total assets $253.5B
Total liabilities $178.2B
Shareholders equity $75.2B
Account 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 Trend
Assets
Cash and Cash Equivalents 2.1% 2.3% 2.3% 4.0% 3.2% 2.9% 2.2% 2.1% 0.9% 1.9%
Short Term Investments 0.5% 0.6% 0.9% 0.9% 1.1% 1.1% 0.9% 1.3% 0.1% 0.0%
Accounts Receivable 9.9% 9.8% 9.8% 8.5% 8.4% 8.1% 7.6% 9.1% 7.1% 6.9%
Inventory 4.8% 4.9% 5.0% 5.9% 6.1% 6.9% 6.8% 8.5% 8.3% 8.3%
Prepaid Expenses 1.3% 0.8% 0.9% 0.8% 1.8% 2.0% 2.0% 2.4% 0.5% 0.4%
Other Current Assets 1.3% 0.8% 0.9% 0.8% 1.8% 2.0% 2.0% 2.4% 0.5% 0.4%
Total Current Assets 18.6% 18.4% 19.0% 20.4% 20.5% 21.0% 19.6% 23.3% 16.9% 17.5%
Property,Plant and Equipment 3.3% 3.5% 3.7% 4.0% 4.4% 4.7% 17.8% 5.9% 5.6% 5.7%
Operating Lease Assets 3.7% 4.3% 4.8% 5.5% 6.5% 7.7% 8.1%
Goodwill 21.3% 24.5% 25.5% 24.2% 27.1% 29.6% 31.1% 40.6% 20.8% 21.5%
Intangible Assets 6.3% 7.3% 8.2% 7.7% 9.9% 11.6% 12.9% 18.8% 7.4% 7.6%
Long Term Investments 8.7% 8.4% 7.3% 7.4% 8.9% 8.9% 7.7% 9.4% 0.1% 0.0%
Other Noncurrent Assets 1.3% 1.3% 1.3% 1.4% 1.6% 1.7% 1.8% 2.6% 0.8% 0.8%
Total Assets 63.1% 67.9% 69.8% 70.8% 79.8% 85.9% 86.6% 101.3% 51.5% 53.2%
Liabilities
Accounts Payable 4.4% 4.3% 4.2% 4.6% 4.3% 4.1% 4.1% 4.6% 4.8% 4.5%
Accrued Liabilities 5.6% 5.6% 6.2% 5.8% 6.0% 5.3% 4.7% 5.5% 3.6% 3.9%
Operating Lease Liabilities 0.4% 0.5% 0.5% 0.5% 0.6% 0.6% 0.6%
Other Current Liabilities 1.2% 1.5% 1.7% 2.1% 0.7% 0.9% 0.8% 1.4% 0.7% 0.9%
Total Current Liabilities 22.1% 22.7% 22.1% 21.6% 23.2% 23.1% 20.8% 22.7% 16.6% 14.8%
Operating Lease Liabilities Noncurrent 3.4% 4.0% 4.5% 5.2% 6.2% 7.0% 7.4% 0.1% 0.2%
Deferred Tax Liabilities 1.0% 1.0% 1.2% 1.2% 2.1% 2.5% 2.8% 4.0% 1.6% 3.3%
Other Noncurrent Liabilities 1.2% 1.5% 1.7% 2.1% 0.7% 0.9% 0.8% 1.4% 0.7% 0.9%
Total Liabilities 44.3% 47.6% 48.4% 48.7% 54.0% 59.9% 61.6% 71.1% 31.1%
Equity
Preferred Stock 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Common Stock 1.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Additional Paid In Capital 12.5% 13.3% 13.7% 14.9% 16.2% 17.3% 17.9% 23.4% 17.4% 17.8%
Retained Earnings 15.2% 16.9% 17.2% 17.4% 18.8% 18.5% 17.6% 21.1% 23.6% 22.0%
Treasury Stock 9.2% 9.9% 9.5% 9.9% 9.6% 10.5% 11.0% 14.6% 20.5% 18.8%
Accumulated Other Comprehensive Income 0.1% -0.0% -0.1% -0.5% 0.3% 0.5% 0.4% 0.1% -0.1% -0.2%
Noncontrolling Interest 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% 0.2% 0.0% 0.0%
Total Stockholders Equity 18.7% 20.3% 21.4% 22.0% 25.7% 25.8% 24.9% 30.0% 20.4% 20.7%
Total Liabilitiesand Equity 63.1% 67.9% 69.8% 70.8% 79.8% 85.9% 86.6% 101.3% 51.5% 53.2%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 10 years
Ratio 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Profitability
Gross margin +45.0% +44.7% +39.3% +38.9% +39.8% +39.0% +38.2% +19.3% +16.9% +17.5%
Operating margin +1.2% +2.3% +3.8% +2.5% +4.6% +5.2% +4.7% +2.1% +5.2% +5.9%
Net margin +0.4% +1.2% +2.3% +1.3% +2.7% +2.7% +2.6% -0.3% +3.6% +3.0%
FCF margin +1.9% +1.7% +2.9% +4.2% +5.4% +5.0% +4.0% +3.5% +3.3% +4.5%
Growth
Revenue CAGR (3y) +7.6% +8.5% +10.0% +7.9% +14.6% +13.3% +13.1% +8.2% +9.9% +11.9%
Returns
ROE +2.4% +6.1% +10.9% +6.1% +10.7% +10.3% +10.4% -1.0% +17.6% +14.4%
ROA +0.7% +1.8% +3.3% +1.9% +3.4% +3.1% +3.0% -0.3% +7.0% +5.6%
ROIC +4.7% +7.9% +14.3% +0.0% +12.4% +10.8%
Liquidity
Current ratio 0.84x 0.81x 0.86x 0.94x 0.88x 0.91x 0.94x 1.03x 1.02x 1.18x
Quick ratio 0.54x 0.53x 0.55x 0.58x 0.50x 0.48x 0.47x 0.49x 0.49x 0.59x
Leverage
D/E 2.37x 2.35x 2.26x 2.21x 2.10x 2.32x 2.48x 2.37x 1.52x 1.56x
Interest coverage 1.49x 2.88x 5.17x 3.48x 5.32x 4.79x 3.95x 1.54x 8.98x 9.63x
Efficiency
Asset turnover 1.59x 1.47x 1.43x 1.41x 1.25x 1.16x 1.15x 0.99x 1.94x 1.88x
Cash conversion cycle +39d +40d +41d +39d +41d +46d +44d +51d +41d +42d

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched
Saving notes adds CVS to your watchlist.